Impact of TRPV1 on Pathogenesis and Therapy of Neurodegenerative Diseases

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2024 Jan 11

PMID 38202764

Authors

Wenxin Wang

Tao Sun

Affiliations

Soon will be listed here.

Abstract

Transient receptor potential vanilloid 1 (TRPV1) is a transmembrane and non-selective cation channel protein, which can be activated by various physical and chemical stimuli. Recent studies have shown the strong pathogenetic associations of TRPV1 with neurodegenerative diseases (NDs), in particular Alzheimer's disease (AD), Parkinson's disease (PD) and multiple sclerosis (MS) via regulating neuroinflammation. Therapeutic effects of TRPV1 agonists and antagonists on the treatment of AD and PD in animal models also are emerging. We here summarize the current understanding of TRPV1's effects and its agonists and antagonists as a therapeutic means in neurodegenerative diseases, and highlight future treatment strategies using natural TRPV1 agonists. Developing new targets and applying natural products are becoming a promising direction in the treatment of chronic disorders, especially neurodegenerative diseases.

Citing Articles

mosGraphGPT: a foundation model for multi-omic signaling graphs using generative AI.

Zhang H, Huang D, Chen E, Cao D, Xu T, Dizdar B bioRxiv. 2024; .

PMID: 39149314 PMC: 11326168. DOI: 10.1101/2024.08.01.606222.

TRPV1 Channels in the Central Nervous System as Drug Targets.

Chahl L Pharmaceuticals (Basel). 2024; 17(6).

PMID: 38931423 PMC: 11206835. DOI: 10.3390/ph17060756.

References

Li H, Mao R, Zhang J, Yang Y, Cao J, Xu L . Antistress effect of TRPV1 channel on synaptic plasticity and spatial memory. Biol Psychiatry. 2008; 64(4):286-92. DOI: 10.1016/j.biopsych.2008.02.020. View

De Miranda B, Goldman S, Miller G, Greenamyre J, Ray Dorsey E . Preventing Parkinson's Disease: An Environmental Agenda. J Parkinsons Dis. 2021; 12(1):45-68. PMC: 8842749. DOI: 10.3233/JPD-212922. View

Alawi K, Keeble J . The paradoxical role of the transient receptor potential vanilloid 1 receptor in inflammation. Pharmacol Ther. 2009; 125(2):181-95. DOI: 10.1016/j.pharmthera.2009.10.005. View

Giordano C, Cristino L, Luongo L, Siniscalco D, Petrosino S, Piscitelli F . TRPV1-dependent and -independent alterations in the limbic cortex of neuropathic mice: impact on glial caspases and pain perception. Cereb Cortex. 2011; 22(11):2495-518. PMC: 3464411. DOI: 10.1093/cercor/bhr328. View

Gao Y, Lu Y, Zhang N, Udenigwe C, Zhang Y, Fu Y . Preparation, pungency and bioactivity of gingerols from ginger ( Roscoe): a review. Crit Rev Food Sci Nutr. 2022; 64(9):2708-2733. DOI: 10.1080/10408398.2022.2124951. View

Busche M, Konnerth A . Neuronal hyperactivity--A key defect in Alzheimer's disease?. Bioessays. 2015; 37(6):624-32. DOI: 10.1002/bies.201500004. View

Wu Z, Yang Q, Crook R, ONeil R, Walters E . TRPV1 channels make major contributions to behavioral hypersensitivity and spontaneous activity in nociceptors after spinal cord injury. Pain. 2013; 154(10):2130-2141. DOI: 10.1016/j.pain.2013.06.040. View

Yang F, Zheng J . Understand spiciness: mechanism of TRPV1 channel activation by capsaicin. Protein Cell. 2017; 8(3):169-177. PMC: 5326624. DOI: 10.1007/s13238-016-0353-7. View

Pasierski M, Szulczyk B . Beneficial Effects of Capsaicin in Disorders of the Central Nervous System. Molecules. 2022; 27(8). PMC: 9029810. DOI: 10.3390/molecules27082484. View

10.

Cao E, Liao M, Cheng Y, Julius D . TRPV1 structures in distinct conformations reveal activation mechanisms. Nature. 2013; 504(7478):113-8. PMC: 4023639. DOI: 10.1038/nature12823. View

11.

Tominaga M, Tominaga T . Structure and function of TRPV1. Pflugers Arch. 2005; 451(1):143-50. DOI: 10.1007/s00424-005-1457-8. View

12.

Wang C, Lu J, Sha X, Qiu Y, Chen H, Yu Z . TRPV1 regulates ApoE4-disrupted intracellular lipid homeostasis and decreases synaptic phagocytosis by microglia. Exp Mol Med. 2023; 55(2):347-363. PMC: 9981624. DOI: 10.1038/s12276-023-00935-z. View

13.

Wang C, Cai Z, Wang W, Wei M, Kou D, Li T . Piperine attenuates cognitive impairment in an experimental mouse model of sporadic Alzheimer's disease. J Nutr Biochem. 2019; 70:147-155. DOI: 10.1016/j.jnutbio.2019.05.009. View

14.

Storozhuk M, Moroz O, Zholos A . Multifunctional TRPV1 Ion Channels in Physiology and Pathology with Focus on the Brain, Vasculature, and Some Visceral Systems. Biomed Res Int. 2019; 2019:5806321. PMC: 6556840. DOI: 10.1155/2019/5806321. View

15.

Stampanoni Bassi M, Gentile A, Iezzi E, Zagaglia S, Musella A, Simonelli I . Transient Receptor Potential Vanilloid 1 Modulates Central Inflammation in Multiple Sclerosis. Front Neurol. 2019; 10:30. PMC: 6361812. DOI: 10.3389/fneur.2019.00030. View

16.

Zygmunt P, Petersson J, Andersson D, Chuang H, Sorgard M, Di Marzo V . Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature. 1999; 400(6743):452-7. DOI: 10.1038/22761. View

17.

Tian Y, Zhang Y, Zhang R, Qiao S, Fan J . Resolvin D2 recovers neural injury by suppressing inflammatory mediators expression in lipopolysaccharide-induced Parkinson's disease rat model. Biochem Biophys Res Commun. 2015; 460(3):799-805. DOI: 10.1016/j.bbrc.2015.03.109. View

18.

Iaccarino H, Singer A, Martorell A, Rudenko A, Gao F, Gillingham T . Gamma frequency entrainment attenuates amyloid load and modifies microglia. Nature. 2016; 540(7632):230-235. PMC: 5656389. DOI: 10.1038/nature20587. View

19.

Benkert J, Hess S, Roy S, Beccano-Kelly D, Wiederspohn N, Duda J . Cav2.3 channels contribute to dopaminergic neuron loss in a model of Parkinson's disease. Nat Commun. 2019; 10(1):5094. PMC: 6841684. DOI: 10.1038/s41467-019-12834-x. View

20.

Li R, Lu Y, Zhang Q, Liu W, Yang R, Jiao J . Piperine promotes autophagy flux by P2RX4 activation in /α-synuclein-induced Parkinson disease model. Autophagy. 2021; 18(3):559-575. PMC: 9037522. DOI: 10.1080/15548627.2021.1937897. View